
Beatrice M. Razzo
Oncology | Hematology
1101 Chestnut Street
Floor 14
Philadelphia, PA 19107
Floor 14
Philadelphia, PA 19107
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Predictors of Delayed Responses to Teclistamab in Multiple Myeloma After Initial Non-Response.
Journal: American journal of hematology
Published: July 30, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.
Journal: Blood cancer journal
Published: June 30, 2025
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium.
Journal: Blood cancer journal
Published: December 27, 2024
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium.
Journal: Blood cancer discovery
Published: December 24, 2024
Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium.
Journal: Blood cancer journal
Published: December 24, 2024
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma.
Journal: Hematology/oncology clinics of North America
Published: December 29, 2023
Options at the time of relapse after anti-BCMA therapy.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 09, 2023
TGFβ+ small extracellular vesicles from head and neck squamous cell carcinoma cells reprogram macrophages towards a pro-angiogenic phenotype.
Journal: Journal of extracellular vesicles
Published: June 09, 2022
Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients.
Journal: Leukemia
Published: November 02, 2021
Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length.
Journal: Leukemia
Published: December 16, 2020
Last Updated: 09/26/2026